Logo

Two HIV vaccine trials show proof of concept for pathway to broadly neutralizing antibodies

Two HIV vaccine trials show proof of concept for pathway to broadly neutralizing antibodies

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus. Traditional approaches haven't worked—largely because HIV mutates rapidly and hides key parts of itself from the immune system.

👉 Full Story